Showing results (1-10 of 173) with videos related to
Sort By:
Pageof 18
Molecular Aspects of Medicine|August 21, 2024
Hepatitis C virus chronicity and oncogenic potential: Vaccine development progressYuki Haga, Sydney Coates, Ranjit RayFrontiers in Immunology|April 6, 2026
Hepatitis C virus E1 protein-specific linear B-cell epitopes, pan-genotype reactivity, and functional relevanceBabu E Preedia, Yuki Haga, Ranjit RayMolecular Carcinogenesis|October 8, 2024
Silmitasertib in Combination With Cabozantinib Impairs Liver Cancer Cell Cycle Progression, Induces Apoptosis, and Delays Tumor Growth in a Preclinical ModelYuki Haga, Ranjit Ray, Ratna B RayNPJ Vaccines|March 19, 2023
Hepatitis C virus E1 and modified E2 delivered from an mRNA vaccine induces protective immunityTapas Patra, Keith Meyer, Yuki Haga, et al.Journal of Virology|September 5, 2025
Hepatitis C virus modified SE2F442NYT-mRNA-LNP candidate vaccine promotes helper CXCR5+T cellsYuki Haga, Preedia Babu E, Marzena Swiderska-Syn, et al.Journal of Virology|December 12, 2023
Hepatitis C virus modified sE2F442NYT as an antigen in candidate vaccine facilitates human immune cell activationYuki Haga, Keith Meyer, Molly M H Sung, et al.The Journal of Biological Chemistry|March 31, 2024
Increased expression of long non-coding RNA FIRRE promotes hepatocellular carcinoma by HuR-CyclinD1 axis signalingYuki Haga, Debojyoty Bandyopadhyay, Mousumi Khatun, et al.Science Translational Medicine|August 5, 2011
Progress toward development of a hepatitis C vaccine with broad shouldersRanjit RayMethods in Molecular Biology (Clifton, N.J.)|May 3, 2014
Evasion of TNF-α-mediated apoptosis by hepatitis C virusHangeun Kim, Ranjit RayJournal of Inflammation (London, England)|December 30, 2022
Bystander effect of SARS-CoV-2 spike protein on human monocytic THP-1 cell activation and initiation of prothrombogenic stimulus representing severe COVID-19Tapas Patra, Ranjit RayPageof 18